Skip to main content

Table 9 Costs of managing metastatic disease

From: The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer

 

Quantity p.a

Price/unit (€)

Total costs p.a. (€)

Responsive

   

Out-patient

   

Specialist practitioner

4

See above

128.28

Medication

   

LHRH Agonist leuprorelin

4

415

1,660

Refractory

   

Medication

   

Docetaxel

17.3

1768

30,645.3

Prednisolon

0.87

10.6

9.2

Bone metastases

   

Out-patient

   

Radiation

14

See Table 5

1,484.06

In-patient

   

Bone scan

0.7

1629.65

1,140.76

Medication

   

Zoledron acid

12

367.98

4,415.76

  1. LHRH = Luteinizing Hormone-Releasing Hormone.
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us